ARCHIVES

Freestanding Cancer Centers May Be The “Missing Ingredient In Cancer Treatment,” DeVita Believes

This article is from The Cancer Letter archive.

Vol. 11 No. 02 | January 11, 1985

Download PDF Visit The Full Archive

Related Articles

Steckel Object To Remarks By Korn Comparing Southern California Centers Unfavorably To NCCP Consortium

November 2, 1984

In Brief : Three Named To Leadership Posts At St. Jude; Mitchell Weiss Appointed Chair of Hematology

July 11, 2014

Faulding, NaPro In Agreement For Marketing Paclitaxel.

March 30, 2001

ODAC Recommends Fludarabine Approval for Refractory CLL

September 21, 1990

Cooperative Group Chairman Blast Cut In’81 Budget

February 15, 1980

Vaccine Prevented Cervical Pre-Cancers, Non-Invasive Cancers In Phase III Trial

October 28, 2005